CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- 4 Open-market sale Chief Scientific Officer sold 28,225 shares at $35.57 ($1,004,008)
- 4 Open-market sale Director sold 47,881 shares at $35.04 ($1,677,741)
- 4 Open-market sale Chief Financial Officer sold 14,983 shares at $35.14 ($526,476)
- 4 Open-market sale Chief Scientific Officer sold 100,000 shares at an average $34.68 ($3,467,764)
- 4 Open-market sale Director sold 30,000 shares at $34.75 ($1,042,500)
- 4 Open-market sale Chief Scientific Officer sold 93,295 shares at an average $33.64 ($3,138,273)
- 4 Open-market sale Chief Scientific Officer sold 50,000 shares at an average $32.62 ($1,631,037)
- 4 Open-market sale Chief Scientific Officer sold 32,308 shares at an average $32.27 ($1,042,660)
- 4 Open-market sale Chief Scientific Officer sold 6,812 shares at an average $32.39 ($220,608)
- 4 Open-market sale Chief Scientific Officer sold 83,372 shares at an average $31.96 ($2,664,216)
- 4 Open-market sale Director sold 3,139 shares at $30.52 ($95,795)
- 4 Grant or award Director acquired 12,848 shares (grant or award)
- 4 Grant or award Director acquired 12,848 shares (grant or award)
- 4 Grant or award Director acquired 12,848 shares (grant or award)
- 4 Grant or award Director acquired 12,848 shares (grant or award)
- 4 Grant or award Director acquired 12,848 shares (grant or award)
- 4 Grant or award Director acquired 12,848 shares (grant or award)
- 4 Grant or award Director acquired 12,848 shares (grant or award)
- 4 Grant or award Director acquired 12,848 shares (grant or award)
- 4 Grant or award Chief People Officer acquired 1,082 shares (grant or award)
Page 18 of 65 · 1,294 filings